Post‐semaglutide weight regain in females with obesity: Associations with gut microbiota, bile acid metabolism, and central nervous system

Documenti analoghi

• Changes in thyroid hormones predict weight regain in patients with obesity who undergo metabolic surgery
  di: Yi Tang, et al.
  Pubblicazione: (2024)
• ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine
  di: Sara Russo, et al.
  Pubblicazione: (2025)
• Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic
  di: Jason M. Samuels, et al.
  Pubblicazione: (2025)
• Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
  di: Erik Stenberg, et al.
  Pubblicazione: (2024)
• Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
  di: Jia‐Jie Wang, et al.
  Pubblicazione: (2024)